Parenteral Estrogen versus Combined Androgen Deprivation in the Treatment of Metastatic Prostatic Cancer – Scandinavian Prostatic Cancer Group (SPCG) Study No. 5

Author： Hedlund Per Olov   Ala-Opas Martti   Brekkan Einar   Damber Jan Erik   Damber Lena   Hagerman Inger   Haukaas Svein   Henriksson Peter   Iversen Peter   Pousette Åke   Rasmussen Finn   Salo Jaakko   Vaage Sigmund   Varenhorst Eberhard  

Publisher： Informa Healthcare

ISSN： 0036-5599

Source： Scandinavian Journal of Urology and Nephrology, Vol.36, Iss.6, 2002-12, pp. : 405-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy - a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

By van der Kwast T.H.   Tetu B.   Candas B.   Gomez J.-L.   Cusan L.   Labrie F.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 523-529

Elsevier

Access to resources Recommend Favorite

A Randomised Comparison of Bicalutamide ('Casodex') 150 mg versus Placebo as Immediate Therapy Either Alone or as Adjuvant to Standard Care for Early Non-Metastatic Prostate Cancer - First Report from the Scandinavian Prostatic Cancer Group Study No. 6

By Iversen P.   Tammela T.L.J.   Vaage S.   Lukkarinen O.   Lodding P.   Bull-Njaa T.   Viitanen J.   Hoisaeter P.   Lundmo P.   Rasmussen F.   Johansson J.-E.   Persson B.-E.   Carroll K.   Scandinavian Prostatic Cancer Group SPCG  

European Urology, Vol. 42, Iss. 3, 2002-09 ,pp. : 204-211

Elsevier

Access to resources Recommend Favorite

Combined androgen blockade for the treatment of metastatic cancer of the prostate

By Schellhammer P.F.  

Urology, Vol. 47, Iss. 5, 1996-05 ,pp. : 622-628

Elsevier

Access to resources Recommend Favorite

Estrogen Receptors in the Human Male Prostatic Urethra and Prostate in Prostatic Cancer and Benign Prostatic Hyperplasia

By Bødker Anders   Bruun Jens   Balslev Eva   Iversen Hans-Georg   Meyhoff Hans-Henrik   Andersson Karl-Erik  

Scandinavian Journal of Urology and Nephrology, Vol. 33, Iss. 4, 1999-09 ,pp. : 237-242

Informa Healthcare

Access to resources Recommend Favorite

Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: Evaluation of cardiovascular events in a randomized trial

By Hedlund Per Olov   Johansson Robert   Damber Jan Erik   Hagerman Inger   Henriksson Peter   Iversen Peter   Klarskov Peter   Mogensen Peter   Rasmussen Finn   Varenhorst Eberhard  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 5, 2011-11 ,pp. : 346-353

Informa Healthcare

Access to resources Recommend Favorite